Advanced Therapy Showcase in Tokyo#1

Glycostem to present at the business partnering event Advanced Therapy Showcase in Tokyo#1 on 21st January at 09.35 CET/17:35 GMT+9 with live streaming.

Kempen Biotech X-over Selection

The Kempen X-over Selection connects a curated list of private European Biotechs with global institutional investors active in the crossover space. 

SVB Leerink Biopharma Private Company Connect
Glycostem to participate in SVB Leerink's Biopharma Private Company Connect from 15th to 17th December, 2020, though virtual one-on-one meeting.
Stifel Virtual Healthcare Conference

Glycostem is invited to participate in the investor conference Stifel Virtual Healthcare Conference on 18th November, 2020, 09:20AM (ET)/15:20PM (CET). Join the meeting through the link to meet our CEO Troels Jordansen.

Annual Cell & Gene Therapy Manufacturing

Glycostem attends the 2nd Annual Cell & Gene Therapy Manufacturing conference virtually. Our CEO Troels Jordansen shares Glycostem world’s first off-the-shelf NK cell-based immunotherapy in the fight against cancer.

Solebury Trout Private Company Showcase

Glycostem participates the 7th Solebury Trout Private Company Showcase co-hosted by BMO and Davis Polk. Glycostem CEO Troels Jordansen presents virtually on Thursday 15th Oct 2020, with featured presentation and Q&A session.